SYY
52
11
EMN
52
-4
NOV
49
-3
CAT
57
2
F
35
-4
STX
50
-2
CAH
47
15
MAT
60
-5
IVZ
52
6
JNPR
59
3
BMY
43
-3
VTR
46
-3
LLY
39
-6
VFC
63
-2
NOC
32
-8
ZTS
36
7
MTB
56
-3
UNH
55
2
KMB
33
2
ILMN
60
4
SYY
52
11
EMN
52
-4
NOV
49
-3
CAT
57
2
F
35
-4
STX
50
-2
CAH
47
15
MAT
60
-5
IVZ
52
6
JNPR
59
3
BMY
43
-3
VTR
46
-3
LLY
39
-6
VFC
63
-2
NOC
32
-8
ZTS
36
7
MTB
56
-3
UNH
55
2
KMB
33
2
ILMN
60
4
Financhill
Back

Denali Therapeutics Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
50

DNLI
Denali Therapeutics

Last Price:
27.45
Seasonality Move:
18.4%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Denali Therapeutics Stock Forecast

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 31% based on the past 6 years of stock performance.
  • Denali Therapeutics has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Denali Therapeutics Stock Undervalued?
    The current Denali Therapeutics [DNLI] share price is $27.05. The Score for DNLI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Denali Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 31% based on the past 6 years of stock performance.

Denali Therapeutics Stock Rating

Sell
50
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics overpriced?

  • Denali Therapeutics has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Denali Therapeutics Stock Price History

Is DNLI stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
denalitherapeutics.com

52-Week Data

52-Week High:
32.13
52-Week Low:
14.56

Prediction Charts

Market Cap:
3.87B
Price in USD:
27.05
Volume:
837.2K
Beta:
1.57

Technical Analysis

SMA50:
27.32
SMA100:
24.95
SMA200:
21.76
52-Wk Change:
42.14%

Stock Predictions

  • Is Denali Therapeutics stock public?
    Yes, Denali Therapeutics is a publicly traded company.
  • What is the Denali Therapeutics stock quote today?
    The Denali Therapeutics stock price is 27.05 USD today.
  • How to buy Denali Therapeutics stock online?
    You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-14 27.90 26.83 27.94 26.64
Oct-15 26.92 26.86 27.07 26.49
Oct-16 27.20 27.66 27.70 26.90
Oct-18 27.51 27.59 28.00 27.43
Oct-21 27.36 26.38 27.49 26.11
Oct-22 26.28 26.29 26.74 25.94
Oct-23 26.12 26.08 26.47 25.85
Oct-24 26.31 26.44 26.60 26.01
Oct-25 26.54 26.15 27.00 26.04
Oct-28 26.50 27.79 27.80 26.23
Oct-29 27.64 27.47 27.74 26.98
Oct-30 27.22 26.85 27.64 26.83
Oct-31 26.64 25.96 26.74 25.55
Nov-1 26.65 27.05 27.49 26.27

Denali Therapeutics Earnings

Denali Therapeutics Earnings Report: Per Share Denali Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Denali Therapeutics Forecast Revenue Growth

Denali Therapeutics Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.54 per share, and a decrease next year of $0.03 per share.

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.